23. Mai 2024
11. April 2024
21. Februar 2024
Leading RNAi therapeutics company - Alnylam has led the translation of RNAi (RNA interference) from Nobel Prize-winning discovery into an innovative, entirely new class of medicines.
Kärtner Ring 5-7, 1010 Wien
+43 (0) 2252 263 263 10
+43 (0) 2252 263 263 40